Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

P3 Health Partners (PIII) EBIT (2020 - 2025)

Historic EBIT for P3 Health Partners (PIII) over the last 6 years, with Q3 2025 value amounting to -$44.2 million.

  • P3 Health Partners' EBIT rose 5866.62% to -$44.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$254.9 million, marking a year-over-year decrease of 345.88%. This contributed to the annual value of -$320.7 million for FY2024, which is 9094.74% down from last year.
  • As of Q3 2025, P3 Health Partners' EBIT stood at -$44.2 million, which was up 5866.62% from -$34.1 million recorded in Q2 2025.
  • Over the past 5 years, P3 Health Partners' EBIT peaked at -$13.0 million during Q1 2021, and registered a low of -$912.2 million during Q2 2022.
  • Its 5-year average for EBIT is -$120.8 million, with a median of -$44.2 million in 2025.
  • In the last 5 years, P3 Health Partners' EBIT crashed by 341232.06% in 2022 and then soared by 9769.42% in 2023.
  • P3 Health Partners' EBIT (Quarter) stood at -$62.0 million in 2021, then plummeted by 765.75% to -$536.5 million in 2022, then surged by 88.02% to -$64.3 million in 2023, then crashed by 115.54% to -$138.5 million in 2024, then surged by 68.07% to -$44.2 million in 2025.
  • Its last three reported values are -$44.2 million in Q3 2025, -$34.1 million for Q2 2025, and -$38.1 million during Q1 2025.